Sofie Trier
Sofie Trier
BASE Life Science
Verified email at baselifescience.com
Title
Cited by
Cited by
Year
A multi-chamber microfluidic intestinal barrier model using Caco-2 cells for drug transport studies
HY Tan, S Trier, UL Rahbek, M Dufva, JP Kutter, TL Andresen
PloS one 13 (5), e0197101, 2018
512018
Membrane fusion of pH-sensitive liposomes–a quantitative study using giant unilamellar vesicles
S Trier, JR Henriksen, TL Andresen
Soft Matter 7 (19), 9027-9034, 2011
262011
Acylation of Glucagon-like peptide-2: interaction with lipid membranes and in vitro intestinal permeability
S Trier, L Linderoth, S Bjerregaard, TL Andresen, UL Rahbek
PLoS One 9 (10), e109939, 2014
212014
A GALA lipopeptide mediates pH-and membrane charge dependent fusion with stable giant unilamellar vesicles
TP Etzerodt, S Trier, JR Henriksen, TL Andresen
Soft Matter 8 (21), 5933-5939, 2012
192012
Acylation of salmon calcitonin modulates in vitro intestinal peptide flux through membrane permeability enhancement
S Trier, L Linderoth, S Bjerregaard, HM Strauss, UL Rahbek, TL Andresen
European Journal of Pharmaceutics and Biopharmaceutics 96, 329-337, 2015
102015
Acylation of Therapeutic Peptides: Interaction with Lipid Membranes and its Implications in Oral Delivery
S Trier, TL Andresen, UL Rahbek, L Linderoth, H Strauss, SB Jensen
DTU Nanotech, 2016
2016
A GALA lipopeptide mediates pH-and membrane charge dependent fusion with stable giant unilamellar vesicles-DTU Orbit (06/03/2019)
TP Etzerodt, S Trier, JR Henriksen, TL Andresen
2012
The system can't perform the operation now. Try again later.
Articles 1–7